Janumet【B】

Hormones and Agents Affecting Hormonal Mechanism: Antidiabetic Agents: Oral Hypoglycemic Agents
OJANU2 “Janumet FC tablet

Each tablet contains sitagliptin 5 mg, metformin HCl 500 mg

適應症:適用於配合飲食和運動,以改善下列第二型糖尿病患者的血糖控制:已在接受Sitagliptin和metformin合併治療者,或僅適用Sitagliptin或metformin但控制不佳者。

Usual dose:

dosage should be individualized based on patient’s current regimen, effectiveness, and tolerability; max. sitagliptin 100 mg and metformin 2000 mg per day

Contraindication: See metformin HCl.

Adverse effect:

Common: asthenia, headache, nasopharyngitis.

Serious: Exfoliative disorder of skin of scalp, Stevens-Johnson syndrome, hypoglycemia, lactic acidosis, pancreatic cancer, pancreatitis, anaphylaxis, hypersensitivity reaction, rhabdomyolysis, abnormal renal function, acute renal failure, angioedema, pancreatic cancer.

Related Entries

(Visited 35 times, 1 visits today)